United States · Biotechnology startup
United States · Sequenom
Sequenom provides genetic analysis products and diagnostic tests for non-invasive prenatal genetic disorders.
Follow Sequenom and see its new rounds in your feed.Sign up free
Funding reportedLast round: Post ipo debt
What company datasets say Sequenom raised
Funding, as reported
Reported in all$185Min dollars
Rounds4
Last roundPost ipo debt
Last round dateSept 2012
Investors listed1
Founders and team
From the SEC filings it signed: 6 on the team.
- Carolyn F. BeaverExecutive Officeri
- Daniel S. GrosuExecutive Officeri
- Dirk van den BoomExecutive Officer, Directori
- Jeff M. LintonExecutive Officeri
- Robin S. WeinerExecutive Officeri
- William S. WelchExecutive Officer, Directori
On the board, as filediCharles M. SlacikDavid M. PendarvisJohn A. FazioKenneth F. BuechlerMyla S. Lai-GoldmanRichard A. LernerRonald M. Lindsay
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Sequenom in front of investors. Or tell us what we have wrong.